The Atlanta Braves have a lot of things to address this offseason, with starting pitching at the top of the list. Atlanta has good pitching depth, but the issues with injuries should have the front office looking for a couple of options.
There are definitely some internal options available, but the Braves must look at some external solutions. The problem is that other contending teams will be doing the same. The biggest name on the market will be Tarik Skubal, and there's little chance he ends up in Atlanta. However, there is another left-hander who may be more affordable in theory.
That pitcher would be Trevor Rogers. Rogers experienced a bit of regression from his impressive 2025 season. However, he was still pretty decent in 2026, with a 4.03 ERA, 39 walks, and 157 strikeouts over 169.2 innings.
His walk and chase rates remained elite during the season. Feels like the kind of pitcher Alex Anthopoulos would target in free agency. Unfortunately, there's a bit of an issue with that as explained by The Athletic's Ken Rosenthal.
Quality offer attached to Trevor Rogers represents a massive hurdle to any hope that Braves target him this offseason
Rogers is the only free agent starter that is attached to a qualifying offer, and that will make a deal a little harder. It could lower the cost, but the Braves may be hesitant to lose a draft pick for him. Rosenthal points out his history of injury as another negative for teams to weigh in their decision-making process. However, at 29, he's one of the youngest free agent starters on the market. ,
The fact that he's one of the top strike throwing pitchers in baseball will make a deal even more attractive. However, the cost in draft picks will likely be way to high for the Braves. Add in the fact that he will be popular among other teams, the Braves will be much better off looking for alternatives.
That's not something fans want to hear, but Anthopoulos has been known to be hesitant to sign players with qualifying offers attached. It's doubtful he would change that with a pitcher who could face regression.
